4//SEC Filing
Henderson Molly 4
Accession 0001209191-23-031647
CIK 0001783183other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 12:15 PM ET
Size
6.2 KB
Accession
0001209191-23-031647
Insider Transaction Report
Form 4
Henderson Molly
CFO and CBO
Transactions
- Sale
Common Stock
2023-05-22$12.87/sh−2,110$27,165→ 70,466 total
Holdings
- 338.86(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 28, 2022.
- [F2]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in two transactions at prices 12.87 and 13.06. The reporting person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001363812
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 12:15 PM ET
- Size
- 6.2 KB